Globus Medical Inc (GMED)

$56.22 -1.62 (-2.80%)
Market Cap 7.87B
Revenue (ttm) 2.52B
Net Income (ttm) 102.98M
EPS (ttm) N/A
PE Ratio 18.30
Forward PE 18.27
Profit Margin 4.09%
Debt to Equity Ratio 0.00
Volume 1,419,026
Avg Vol 1,381,120
Day's Range N/A - N/A
Shares Out 135.06M
Stochastic %K 5%
Beta 1.16
Analysts Strong Sell
Price Target $83.00

Company Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 930 1800
Address:
2560 General Armistead Avenue, Audubon, United States
NVDAMillionaire
NVDAMillionaire Sep. 8 at 12:56 PM
$GMED Excellent article that nails exactly where GMED stands right now. So if you want to update your GMED knowledge or get acquainted with GMED, this is a must read. https://beyondspx.com/quote/GMED/analysis/globus-medical-s-ecosystem-ascendancy-robotics-acquisitions-and-a-clear-path-to-musculoskeletal-dominance-nyse-gmed
0 · Reply
ZacksResearch
ZacksResearch Sep. 4 at 6:19 PM
$GMED — Hold or fold? ⚖️ The company is benefiting from strong musculoskeletal demand and new product launches, but it’s also up against currency headwinds and intense competition. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2747332/should-you-hold-onto-globus-medical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2747332-teaser-11037&ADID=SYND_STOCKTWITS_TWEET_2_2747332_TEASER_11037
0 · Reply
ZacksResearch
ZacksResearch Sep. 4 at 5:19 PM
$GMED declined 16.6% compared to the industry's 15.2% fall — but is it a hidden gem in the medical space? 💎 🔬 Strong U.S. Spine business and promising new product launches 📈 Recent Nevro acquisition unlocks a $2.5B market opportunity 📊 Average earnings surprise of 10.8% over the past four quarters See if GMED's growth prospects outweigh the headwinds 👉 https://www.zacks.com/stock/news/2747332/should-you-hold-onto-globus-medical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2747332-body-11024&ADID=SYND_STOCKTWITS_TWEET_2_2747332_BODY_11024
0 · Reply
MarketCrown
MarketCrown Aug. 27 at 6:37 AM
$GMED choppy movement, waiting for clearer direction.
0 · Reply
Mitz007
Mitz007 Aug. 20 at 12:23 AM
$GMED AH price inaccurate its 61.17
0 · Reply
Mitz007
Mitz007 Aug. 20 at 12:16 AM
$GMED wow 🤯 AH down - what changed for GMED , MDT pulling this down , no reason …
0 · Reply
ZacksResearch
ZacksResearch Aug. 13 at 12:48 PM
$GMED posts a strong Q2 beat — what's driving the surge? 🚀 Adjusted EPS of 86 cents topped estimates by 13.16%, with worldwide sales climbing 18.4% YoY to $745.3M. Notably, the Nevro acquisition contributed $95M in revenue, boosting sales. 📈 Discover the full story here 👉 https://www.zacks.com/stock/news/2706730/globus-medical-stock-up-on-q2-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2706730-body-7571&ADID=SYND_STOCKTWITS_TWEET_2_2706730_BODY_7571
0 · Reply
ZacksResearch
ZacksResearch Aug. 13 at 11:48 AM
$GMED pops after Q2 beat 📈 Earnings and revenues topped expectations, and margins expanded — a strong combo that signals operational strength. Full breakdown here 👉 https://www.zacks.com/stock/news/2706730/globus-medical-stock-up-on-q2-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2706730-teaser-7561&ADID=SYND_STOCKTWITS_TWEET_2_2706730_TEASER_7561
0 · Reply
Mitz007
Mitz007 Aug. 13 at 12:13 AM
$GMED Slowly chugging along lets fill the gap up now ..
0 · Reply
nycowboy
nycowboy Aug. 12 at 7:24 PM
$GMED On cruise control back to 90
0 · Reply
Latest News on GMED
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

Aug 28, 2025, 4:30 PM EDT - 20 days ago

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:05 PM EDT - 5 weeks ago

Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript

Globus Medical Reports Second Quarter 2025 Results

Aug 7, 2025, 4:15 PM EDT - 5 weeks ago

Globus Medical Reports Second Quarter 2025 Results

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

Jul 21, 2025, 8:00 AM EDT - 2 months ago

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

Jul 17, 2025, 4:30 PM EDT - 2 months ago

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Jul 15, 2025, 4:15 PM EDT - 2 months ago

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Globus Medical: Obtaining My Backing Again

Jul 3, 2025, 12:10 PM EDT - 2 months ago

Globus Medical: Obtaining My Backing Again

Globus Medical Announces $500 Million Share Repurchase Program

May 15, 2025, 4:30 PM EDT - 4 months ago

Globus Medical Announces $500 Million Share Repurchase Program

Medical, Inc. Company Investigated by the Portnoy Law Firm

May 13, 2025, 6:28 PM EDT - 4 months ago

Medical, Inc. Company Investigated by the Portnoy Law Firm

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:32 PM EDT - 4 months ago

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

Globus Medical Reports First Quarter 2025 Results

May 8, 2025, 4:15 PM EDT - 4 months ago

Globus Medical Reports First Quarter 2025 Results

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Apr 17, 2025, 4:30 PM EDT - 5 months ago

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Globus Medical completes acquisition of Nevro Corp.

Apr 3, 2025, 8:31 AM EDT - 5 months ago

Globus Medical completes acquisition of Nevro Corp.

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

Mar 21, 2025, 11:30 AM EDT - 6 months ago

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

NVRO

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Mar 11, 2025, 4:40 PM EDT - 6 months ago

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Mar 6, 2025, 4:40 PM EST - 6 months ago

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Mar 5, 2025, 7:01 PM EST - 6 months ago

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

Mar 4, 2025, 4:15 PM EST - 7 months ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

NVRO

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:54 PM EST - 7 months ago

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:15 PM EST - 7 months ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Feb 6, 2025, 9:30 AM EST - 7 months ago

Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients

Top 2 Health Care Stocks That May Crash In February

Feb 5, 2025, 6:57 AM EST - 8 months ago

Top 2 Health Care Stocks That May Crash In February

OFIX

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Jan 30, 2025, 4:35 PM EST - 8 months ago

Globus Medical Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Jan 8, 2025, 4:30 PM EST - 9 months ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

Jan 8, 2025, 12:10 PM EST - 9 months ago

The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors

Four hidden gems in the stock market from a five-star fund manager

Dec 16, 2024, 1:32 PM EST - 9 months ago

Four hidden gems in the stock market from a five-star fund manager

CARG PGNY TXRH

Globus Medical Launches ExcelsiusHub™ Navigation System

Nov 22, 2024, 4:30 PM EST - 10 months ago

Globus Medical Launches ExcelsiusHub™ Navigation System

Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 8:12 PM EST - 11 months ago

Globus Medical, Inc. (GMED) Q3 2024 Earnings Call Transcript

Globus Medical Reports Third Quarter 2024 Results

Nov 5, 2024, 4:15 PM EST - 11 months ago

Globus Medical Reports Third Quarter 2024 Results

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud

Nov 3, 2024, 11:00 AM EST - 11 months ago

The Schall Law Firm Encourages Investor Participation In An Inquiry Into Globus Medical Inc For Securities Fraud

NVDAMillionaire
NVDAMillionaire Sep. 8 at 12:56 PM
$GMED Excellent article that nails exactly where GMED stands right now. So if you want to update your GMED knowledge or get acquainted with GMED, this is a must read. https://beyondspx.com/quote/GMED/analysis/globus-medical-s-ecosystem-ascendancy-robotics-acquisitions-and-a-clear-path-to-musculoskeletal-dominance-nyse-gmed
0 · Reply
ZacksResearch
ZacksResearch Sep. 4 at 6:19 PM
$GMED — Hold or fold? ⚖️ The company is benefiting from strong musculoskeletal demand and new product launches, but it’s also up against currency headwinds and intense competition. Full bull/bear breakdown here 👉 https://www.zacks.com/stock/news/2747332/should-you-hold-onto-globus-medical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2747332-teaser-11037&ADID=SYND_STOCKTWITS_TWEET_2_2747332_TEASER_11037
0 · Reply
ZacksResearch
ZacksResearch Sep. 4 at 5:19 PM
$GMED declined 16.6% compared to the industry's 15.2% fall — but is it a hidden gem in the medical space? 💎 🔬 Strong U.S. Spine business and promising new product launches 📈 Recent Nevro acquisition unlocks a $2.5B market opportunity 📊 Average earnings surprise of 10.8% over the past four quarters See if GMED's growth prospects outweigh the headwinds 👉 https://www.zacks.com/stock/news/2747332/should-you-hold-onto-globus-medical-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2747332-body-11024&ADID=SYND_STOCKTWITS_TWEET_2_2747332_BODY_11024
0 · Reply
MarketCrown
MarketCrown Aug. 27 at 6:37 AM
$GMED choppy movement, waiting for clearer direction.
0 · Reply
Mitz007
Mitz007 Aug. 20 at 12:23 AM
$GMED AH price inaccurate its 61.17
0 · Reply
Mitz007
Mitz007 Aug. 20 at 12:16 AM
$GMED wow 🤯 AH down - what changed for GMED , MDT pulling this down , no reason …
0 · Reply
ZacksResearch
ZacksResearch Aug. 13 at 12:48 PM
$GMED posts a strong Q2 beat — what's driving the surge? 🚀 Adjusted EPS of 86 cents topped estimates by 13.16%, with worldwide sales climbing 18.4% YoY to $745.3M. Notably, the Nevro acquisition contributed $95M in revenue, boosting sales. 📈 Discover the full story here 👉 https://www.zacks.com/stock/news/2706730/globus-medical-stock-up-on-q2-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2706730-body-7571&ADID=SYND_STOCKTWITS_TWEET_2_2706730_BODY_7571
0 · Reply
ZacksResearch
ZacksResearch Aug. 13 at 11:48 AM
$GMED pops after Q2 beat 📈 Earnings and revenues topped expectations, and margins expanded — a strong combo that signals operational strength. Full breakdown here 👉 https://www.zacks.com/stock/news/2706730/globus-medical-stock-up-on-q2-earnings-revenue-beat-margins-expand?cid=sm-stocktwits-2-2706730-teaser-7561&ADID=SYND_STOCKTWITS_TWEET_2_2706730_TEASER_7561
0 · Reply
Mitz007
Mitz007 Aug. 13 at 12:13 AM
$GMED Slowly chugging along lets fill the gap up now ..
0 · Reply
nycowboy
nycowboy Aug. 12 at 7:24 PM
$GMED On cruise control back to 90
0 · Reply
Crom5775
Crom5775 Aug. 10 at 7:03 PM
$GMED clean break over trend line. Closing above its 50 days moving average
0 · Reply
CeaseNDesist
CeaseNDesist Aug. 8 at 8:09 PM
$GMED awesome day
0 · Reply
Mitz007
Mitz007 Aug. 8 at 6:51 PM
$GMED came quite close so next week will be past 60
0 · Reply
wahoowa96
wahoowa96 Aug. 8 at 2:30 PM
$GMED All tech AI, Semi, nuclear, gold are overrated and ridiculously expensive. Guys holding low priced shares can buy and sell themselves but not me. It's a good place here at GMED way overlooked by greedy market looking for sexy instant gratification.
0 · Reply
nycowboy
nycowboy Aug. 8 at 2:02 PM
$GMED
0 · Reply
Mitz007
Mitz007 Aug. 8 at 12:28 AM
$GMED let’s tap 60 tomorrow ..
0 · Reply
Shhhhhhhhhhhhh01
Shhhhhhhhhhhhh01 Aug. 7 at 8:47 PM
$GMED is it a really good earning? I don’t think so
2 · Reply
Estimize
Estimize Aug. 7 at 3:00 PM
$GMED reports after the close, Estimize Consensus +0.02 EPS and +5.97M Revs compared to WS http://www.estimize.com/gmed/fq2-2025?utm_conten
0 · Reply
nycowboy
nycowboy Aug. 7 at 10:00 AM
$GMED She finally closed that nasty gap back in May.. giddy up
0 · Reply
scientificway
scientificway Aug. 3 at 4:30 AM
$GMED check MDXG out, huge revenue growth, eps growth
0 · Reply
JarvisFlow
JarvisFlow Jul. 22 at 2:14 PM
Canaccord Genuity has adjusted their stance on Globus Medical ( $GMED ), setting the rating to Buy with a target price of 97 → 90.
0 · Reply
AlphaRR
AlphaRR Jul. 21 at 9:27 PM
$MEDP one of my long term holdings picked up during Covid era . Great solid play on Pharma without the risk of a trial not working. Sold half kept half , this is a hell of a spike , but if you think about they raised guidance to $15 in earnings , so at 460 it's only 30x PE not so bad So I kept half A name not talked about often but a solid growth play , those earnings were strong as fuck! One day I'll have the same type of returns on the 2 med techs I bought today $XRAY and $GMED
0 · Reply